A Pharmaceutical Executive on Trump’s Tariff Strategy
Earlier this month, President Donald Trump announced the U.S. would impose up to a 200% tariff on imported pharmaceuticals, though he would give them up to a year and a half before fully implementing the tariffs. Trump’s goal is to bring more manufacturing to the United States, but one pharmaceutical CEO, Richard…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like The Journal. →
The fallout of Trump’s tariff setback at the Supreme Court
Stocks Surge On Tariff Cuts… And Trump’s Drug Pricing Executive Order 5/12/25
More Trump Tariffs Are Coming
The Unintended Consequences of Trump’s Tariff Strategy
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.